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Naturally occurring and laboratory generated animal models serve as powerful tools with which to inves-
tigate the etiology of human retinal degenerations, especially retinitis pigmentosa (RP), Leber congenital
amaurosis (LCA), cone dystrophies (CD) and macular degeneration (MD). Much progress has been made
in elucidating gene defects underlying disease, in understanding mechanisms leading to disease, and in
designing molecules for translational research and gene-based therapy to interfere with the progression
of disease. Key to this progress has been study of naturally occurring murine and canine retinal degen-
eration mutants. This article will review the history, phenotypes and gene defects of select animal models
with outer retina (photoreceptor and retinal pigment epithelium) degeneration phenotypes.
 2009 Elsevier Ltd. All rights reserved.1. Introduction
Gene defects linked to retinal dystrophies in human and animal
models cover a wide range of phenotypes, from non-progressive
night blindness to early or late-onset retinal degeneration,
inherited in dominant, recessive, autosomal or X-linked fashion
(for a comprehensive list of retina dystrophy genes, see Ret-
Net@www.sph.uth.tmc.edu). Many genes affecting vision are
expressed in either photoreceptors where phototransduction oc-
curs or the retinal pigmented epithelium (RPE) where the chromo-
phore of visual pigments is recycled. Mutations in photoreceptor
genes leading to blindness involve a large variety of gene products,
including components of the phototransduction cascade, the reti-
noid cycle, structural proteins, transcription factors, and vesicular
transport. Retinitis pigmentosa typically affects rod photoreceptors
ﬁrst, producing night blindness and attenuated peripheral vision,
then progresses to involve cones and central vision as well (Har-
tong, Berson, & Dryja, 2006). As the disease progresses, peripheral
vision is gradually lost and cones are also affected. Signs and symp-
toms often ﬁrst appear in childhood, but severe visual problems of-
ten do not develop until early adulthood. Multiple RP subtypes
exist, and in the United States, an estimated 100,000–200,000 peo-
ple have some form of RP. In Leber congenital amaurosis, rod and
cone photoreceptor function is absent or severely compromised
at birth, as evidenced by extinguished or barely detectable phot-
opic and scotopic electroretinograms (ERGs). As with RP, LCA is
highly heterogeneous and at least eleven LCA subtypes link to asll rights reserved.many unrelated genes (den Hollander, Roepman, Koenekoop, &
Cremers, 2008). Macular degeneration (MD) is a disorder of the
macula and RPE causing decreased central visual acuity. Break-
down of the RPE interferes with phagocytosis and the retinoid cy-
cle, causing thinning of the retina and new blood vessel growth.
MD becomes increasingly frequent in people beyond age 50, affect-
ing 25% of people aged 75 years and older (Brown et al., 2005;
Stone, 2007).
In most cases, there is only rudimentary understanding of the
pathobiology leading to retinal degeneration, and no safe therapy
or cure. Historically, naturally occurring animal models (e.g., mu-
tant mice, cats, dogs) have been especially useful in determining
biochemical mechanisms and phenotypes. For example, the retinal
degeneration (rd) mouse, to our knowledge the ﬁrst published ver-
tebrate photoreceptor degeneration model, was described in 1924
(Keeler, 1924). The last ﬁfteen years have seen an explosion in lab-
oratory generated mouse models by transgenic or gene replace-
ment technologies, but naturally or spontaneously occurring
models are still being discovered at The Jackson Laboratory. While
the mouse has become a standard animal model for retinitis pig-
mentosa and cone dystrophies (Chang et al., 2005; Dalke & Graw,
2005), emphasis has shifted to larger animal models (e.g., dogs or
monkeys) since the eyes of these animals are more human-like
and are more amenable to pre-clinical gene-based therapies. In re-
cent years, signiﬁcant progress has been made with viral gene
replacement therapy particularly in canine models with retinal
degeneration (Acland et al., 2001, 2005a). To illustrate the utility
of animal models for understanding mechanisms that lead to reti-
nopathy, we summarize current ﬁndings for animal retinal dystro-
phies and examine the underlying genetic defects.
Fig. 1. N-terminal regions of the wt (top) and nob2 (middle, bottom) a1F channel subunit. The amino acid sequences starts at the translocation initiator, M, in exon 1. The
area shaded in blue is replaced by the transposon sequence shown in red. The middle sequence shows the truncation after residue 25 (adapted from (Doering et al., 2008). In
the bottom sequence, the stop codon was removed by alternative splicing. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web
version of this article.)
W. Baehr, J.M. Frederick / Vision Research 49 (2009) 2636–2652 26372. Cacna1f (CaV1.4 or a1F Ca2+ channel subunit): nob2 mouseVoltage activated Ca2+ channels are multimeric complexes com-
posed of a pore-forming a1 subunit and several regulatory sub-
units. a1F, encoded by the CACNA1F gene, is a retina-speciﬁc
member of the L-type family of Ca2+ channel a1 subunits medi-
ating glutamate release at mammalian retinal ribbon synapses.
In the dark, a1F is open and active producing Ca2+ inﬂux into the
synaptic terminal and glutamate release. Light hyperpolarizes
photoreceptors, an event which closes a1F and reduces gluta-
mate release (recent review: (Morgans et al., 2005).
Identiﬁed at The Jackson Laboratory, nob2 mice were shown to
have a reduced rod b-wave (as distinguished from nob mice which
have no b-wave) (Chang, Heckenlively, et al., 2006). The nob2 rod a-
wave is unaffected, while cone b-waves are reduced. The pheno-
type resembles incomplete X-linked congenital stationary night-
blindness (CSNB2) in humans caused by CACNA1F null alleles
(Bech-Hansen et al., 1998). The OPL of the nob2 retina is disorga-
nized, i.e. horizontal cells were observed to extend dendritic pro-
cesses into the photoreceptor layer and mGluR6 of bipolar cell
dendrites could be immunodetected in the ONL (Chang, Hecken-
lively, et al., 2006; Bayley & Morgans, 2007).
The nob2 gene defect was identiﬁed as a transposon (ETn) inser-
tion in exon 2 of the Cacna1f gene located on the X-chromosome
and encoding the a1F subunit of the voltage-dependent Ca2+ chan-
nel a1F. This insertion produces a null allele and translational stop
after codon 26. However, the phenotype of a laboratory generated
Cacna1f knockout mouse (G305ter, complete loss of the rod b-
wave) was more severe than that of the nob2 mouse (Mansergh
et al., 2005). Doering et al. (2008) discovered by RNA analysis that
the nob2 retina actually expresses two mRNA species, one with the
stop codon at position 33 and a second mRNA in which the stop
was removed, presumably by alternative splicing occurring within
Etn transposon. This RNA produced a a1F protein in which a 22-res-
idue segment (pos. 10–31) was replaced by 24-residue section
deriving from Etn (Fig. 1). As a consequence, the mutant a1F lost
its ability to interact with ﬁlamins A and B (Doering et al., 2008).
The nob2 and human CSNB2 phenotype is restricted to the ret-
ina and is non-progressive, consistent with expression of a1F in
photoreceptor synapses. Mechanistically, loss of functional CAC-Fig. 2. The murine Cep290 gene. In the rd16mouse, exons 35–39 are deleted, thereby rem
and 40 in-frame. In the rdAc cat gene, a single nucleotide polymorphism (SNP) generate
legend, the reader is referred to the web version of this article.), resulting in the truncatio
in gray).NA1F leads to block of synaptic transmission from photoreceptors
to bipolar cells. The human CACNA1F gene is also associated with
Aland Island eye disease characterized by fundus hypopigmenta-
tion and decreased visual acuity (Wutz et al., 2002).
3. Cep290 (centrosomal protein of 290 kDa): rd16 mouse, rdAc
Abyssinian catCEP290, also known as nephrocystine 6 (NPHP6), localizes to
the centrosome (microtubule organizing center) of dividing
cells, and in photoreceptors, to the connecting cilium in rods
and cones. In humans, loss-of-function mutations in the
CEP290 gene have been associated with Joubert syndrome
(affecting the controls of balance and coordination in the brain)
(Sayer et al., 2006; Valente et al., 2006), nephronophthisis
(medullary cystic kidney disease), and hypomorphic mutations
with Leber Congenital Amaurosis (LCA10) (disabling rod and
cone function) (den Hollander et al., 2006).
The rd16 mouse is a spontaneous mutant discovered at The Jack-
son Laboratory (Chang, Khanna, et al., 2006). An in-frame deletion
of 298 amino acids (exons 35–39) of Cep290 (Fig. 2) causes a rap-
idly progressing degeneration that is complete by 6 weeks postna-
tally. Scotopic and photopic ERG a-wave amplitudes, diminished
by PN18, are absent at PN28. CEP290-LCA in humans and rd16mice
show abnormal olfactory function, and abnormal transport of
membrane-associated Ga-olf (Gnal) and Gc13 (Gng13), both of
which are subunits of the olfactory G protein (McEwen et al.,
2007). Despite loss of vision and olfaction, cilia of photoreceptors
and olfactory sensory neurons (OSN) appear normal. Rhodopsin
and arrestin mislocalized to the rd16 ONL suggesting a role for
CEP290 in membrane protein transport.
CEP290 (2,479 amino acids) has multiple motifs, including
coiled-coil domains (an a-helical heptad repeat of amino acids
from 1 to 7 where 1 and 4 are hydrophobic and 5 and 7 predomi-
nantly polar) and an ATP/GTP binding loop, among other motifs
(Chang, Khanna, et al., 2006). CEP290 was shown to be associated
with RPGR-interacting protein (RPGRIP), dynactin subunits, kine-
sin-II subunits KIF3A and KAP3, centrin-1, periciliary membrane
protein 1 (PCM1) (Chang, Khanna, et al., 2006) and other centro-
somal proteins, e.g., CP110 (Tsang et al., 2008). CEP290 is part ofoving 298 amino acids in the C-terminal half of CEP290. The deletion joins exons 34
s a new splice site (blue) (For interpretation of the references to color in this ﬁgure
n of cat CEP290 by 159 residues. The protein has multiple coiled-coil motifs (shaded
Table 1
Naturally occurring animal models. The animal models are ordered alphabetically by their mutant genes. Column 1, gene symbols; column 2, the gene product; column 3,
commonly used trivial names for the animal model; column 4, gene defects; column 5, animal phenotypes; column 6, human phenotypes with mutations in orthologous genes;
column 7, references. Abbreviations used: RP, retinitis pigmentosa; LCA, Leber’s congenital amaurosis; CSNB, congenital stationary night blindness; ar, autosomal recessive; ad,
autosomal dominant; X, X-linked; D, deletion.
Gene Protein Animal
model
Gene defect Animal phenotype Human disease References
Cacna1f VDCC a1F
subunit (CaV1.4)
nob2 mouse insertion of
Etn transposon
into X2
Reduced rod b-wave, disorganized
OPL, non-progressive
Incomplete X-linked CSNB (CSNB2) Chang,
Heckenlively,
et al. (2006)
CEP290 Centrosomal
protein 290 kDa
rd16 mouse Dexons 35–
39)
ERG absent at PN28, abnormal
olfaction
Joubert syndrome nephronophthisis LCA Chang, Khanna,
et al. (2006)
CEP290 Centrosomal
protein 290 kDa
rdAc cat IVS50 + 9T > G Progressive retina atrophy, complete
degeneration at 3–5 years
Menotti-
Raymond et al.
(2007)
Chx10 C. elegans ceh-
10 homeo
domain
containing
homologue
Chx10 ocular
retardation,
or
Y176ter Abnormal eye development (ocular
retardation (or), rudimentary eyes,
optic nerve absent
Microphthalmia Burmeister et al.
(1996) and Ferda
et al. (2000)
Cngb3 Cone CNG
channel b
subunit
Alaskan
Malamute
dog
D all exons Day blindness at 8–12 weeks, cone
dystrophy
Total color blindness (ACHM3) Sidjanin et al.
(2002)
Cngb3 Cone CNG
channel b
subunit
German
shorthaired
pointer
D262 N Day blindness at 8–12 weeks, cone
dystrophy
Total color blindness (ACHM3) Sidjanin et al.
(2002)
Crb1 Drosophila
Crumbs
homolog 1
rd8 mouse Dnt3481 in
exon 9
Slowly progressing retinal
degeneration with relatively stable
ERGs
RP, LCA Mehalow et al.
(2003)
Gnat2 Cone transducin
a subunit
cpﬂ3 mouse D200 N in
exon 6
At PN28, near normal scotopic ERGs,
reduced cone b-wave amplitudes; at
9 months, undetectable cone ERGs
Recessive achromatopsia (rod
monochromacy)
Chang, Dacey,
et al. (2006) and
Kohl et al. (2002)
Gnb1 Transducin b-
subunit
rd4+/
mouse
inverted Rd4
chromosome 4
breakpoint in
intron 2
rd4+/ mouse: recessive Kitamura et al.
(2006)RP
rd4/ mouse: lethal
Gnb3 Cone transducin
b-subunit
rge chicken
(retinopathy
globe
enlarged)
DD153 Cone ERG reduced at hatch, but still
present at one year. Scotopic and
photopic b-waves oscillatory
potentials absent
Tummala et al.
(2006)
Grm6 Metabotropic
glutamate
receptor 6
(mgluR6)
nob3 mouse S207P Lack of scotopic and photopic b-waves CSNB1B Maddox et al.
(2008) and Dryja
et al. (2005)
Grm6 Metabotropic
glutamate
receptor 6
(mgluR6)
nob4 mouse IVS1ins65nt Lack of scotopic and photopic b-waves CSNB1B Pinto et al. (2007)
and Dryja et al.
(2005)
Gucy2e Guanylate
cyclase 1
rd chicken
(GUCY1B)
Dexons 4–7 No ERG measurable at hatch; slowly
progressing degeneration
LCA Semple-Rowland
et al. (1998)
Mertk Mertk gene (c-
mer proto-
oncogene
tyrosine kinase)
RCS rat Dexon 2 Retinal degeneration Recessive RP cone–rod dystrophy D’Cruz et al.
(2000), Gal et al.
(2000), and
McHenry et al.
(2004)
Mfrp Membrane-type
frizzled-related
protein (Mfrp)
rd6 mouse Dexon 4 Discrete subretinal spots across the
retina; progressive retinal
degneration
Human null alleles: nanophthalmos,
characterized by extreme hyperopia and
late-onset retinal macular degeneration
Kameya et al.
(2002) and
Sundin et al.
(2005)
Myo7a Myosin VIIA sh1 mouse
(shaker-1
mouse)
Sh1 R502P Sh1/sh1 mice show circling, head-
tossing, deafness, and hyperactivity
phenotypes
Human Null alleles: Usher syndrome
Type 1B
Liu et al. (1998)
and Weil et al.
(1995)
Sh16J R241P
Nr2e3 Photoreceptor-
speciﬁc Nuclear
Receptor (PNR)
rd7 mouse Dexon 4–5 Retinal degeneration characterized by
whorls and rosettes in the ONL.
Enhanced S-cone syndrome Akhmedov et al.
(2000)
Nyx Nyctalopin nob1 mouse 85 bp deletion No rod b-wave, normal rod a-wave
and cone ERG
X-linked CSNB1A (no b-wave) Gregg et al.
(2003)
Pde6a Rod PDE6 a
subunit
rcd3
Cardigan
Welsh corgi
X15Dnt1939 Arrest in outer segment formation;
progressive retinal atrophy (PRA).
Null alleles: autosomal recessive RP Huang et al.
(1995) and
Petersen-Jones
et al. (1999)
PDE6b Rod PDE b
subunit
rd1 mouse (r
mouse)
Y347ter Failure to elaborate normal outer
segments, and rapid degeneration
following eye opening at P12.
Null alleles: autosomal recessive RP Pittler et al.
(1993)
Pde6b Rod PDE b
subunit
rd10 mouse R560C in exon
13
Measurable scotopic ERG at P18–P30,
later onset of RP than in the rd1
mouse; rods are gone by P30–35,
cones die later.
(Chang et al.,
2002)
(continued on next page)
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Table 1 (continued)
Gene Protein Animal
model
Gene defect Animal phenotype Human disease References
Pde6b Rod PDE b
subunit
rcd1 Irish
setter
W807ter Progressive retinal atrophy (PRA) (Suber et al.
(1993))
Pde6b Rod PDE b
subunit
Sloughi dog C816ins8nt Progressive retinal atrophy (PRA) Dekomien et al.
(2000)
Prph2 Peripherin/Rds rd2 mouse
(rds mouse)
9.2 kb
insertion in
exon 2 after
codon 229
No outer segments, no scotopic or
photopic ERG response. ONL
disappears completely after about
1 year
Null alleles: recessive RP. Missense
mutations cause dominant macular
dystrophy, digenic RP with ROM1, and
dominant adult vitelliform macular
dystrophy
Sanyal and Jansen
(1981) and Travis
et al. (1989)
Rd3 RD3 rd3 mouse R107ter Rod/cone degeneration similar to
human LCA
Friedman et al.
(2006)
Rho Rhodopsin English
mastiff dog
T4R Retinal degeneration that mimics
dominant RP in humans with T4 K
RHO mutations
adRP Kijas et al. (2002)
Rpe65 Retinal pigment
epithelium
protein of
65 kDa
Swedish
Briard-
BeagleDog
D4 bp exon 5
(485delAAGA)
Night blindness, much reduced day
vision, but normal fundi; slowly
progressing degeneration
LCA Aguirre et al.
(1998) and Veske
et al. (1999)
Rpe65 Retinal pigment
epithelium
protein of
65 kDa
rd12 mouse R44ter After 5 months, white spots visible
throughout the fundus by
ophthalmoscopy;. Scotopic ERG
severely attenuated; photopic
responses recordable.
LCA Pang et al. (2005)
Rpgr RPGR (Retinitis
Pigmentosa
GTPase
Regulator
XLPRA1
Siberian
husky
D5 bp in
ORF15
Normal retinal morphology until early
adulthood. After age 6 months, severe
anomalies develop.
XLRP (RP3) Zhang et al.
(2002)
Rpgr RPGR XLPRA2 D2 bp in
ORF15
Early onset degeneration;
disorganized outer segments during
photoreceptor development
XLRP Zhang et al.
(2002)
Rpgrip RPGR-
interacting
protein
Dachshund Insertion of 44
nt in exon 2
Recessive cone/rod dystrophy LCA Lheriteau et al.
(2009) and
Mellersh et al.
(2006)
Tub Tubby protein
(TUB)
rd5 mouse
tubby
mouse
G18,626T
splice site
mutation
DX12
Late onset obesity, retinal/cochlear
degeneration, reduced fertility, insulin
resistance
Chang et al.
(2002)
Fig. 3. The Chx10/Vsx2 gene. In the orJmouse, a nonsense codon in exon 3 truncates
the transcription factor in the center of the Hox domain. OAR (named after the
initials of otp, aristaless, and rax) is a 14-aa motif identiﬁed within the C-terminal
region of several paired-like homeodomain-containing proteins.
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which include rab8 (a small GTPase involved in vesicular trans-
port) and components of the BBSome, a stable complex of at least
seven BBS proteins involved in membrane protein trafﬁcking (Kim,
Krishnaswami, & Gleeson, 2008; Loktev et al., 2008).
Abyssinian Cat. Another naturally occurring Cep290 mutant is
the long-studied Abyssinian retinal degeneration cat model (rdAc).
Progressive retina atrophy (PRA) in the Abyssinian cat was re-
corded by Swedish researchers almost 30 years ago (Narfstrom,
1983). The retina phenotype of the mutant cat resembles a slowly
developing recessive RP, with reduced ERG a-wave amplitudes at
7 months, and complete photoreceptor degeneration at 3–5 years
of age. The CEP290 gene defect was recently identiﬁed as a SNP
of intron 50 (Table 1), generating a new splice site, a 4 bp insertion
and a CEP protein that is shortened by 159 amino acids (Menotti-
Raymond et al., 2007).
4. Chx10/Vsx2 (ceh10 homeodomain-containing homolog/visual
system homeobox 2): orJ mouseCHX10 (now called Vsx2) is a homeodomain-containing tran-
scription factor that is expressed exclusively in retinal progeni-
tors, and plays a critical role in the formation of the neural
retina. Recessive CHX10 mutations were shown to segregate
with microphthalmia in human patients.
The mouse mutant orJ (ocular retardation J) is characterized by
abnormal eye development (TRUSLOVE, 1962). Or J mice are blind,
with rudimentary eyes, cataracts, and no optic nerve. The or J geneencodes VSX2/CHX10, a transcription factor expressed in retinal
progenitor cells during development (optic cup stage) (Liu et al.,
1994). Expression of VSX2/CHX10 is lost in postmitotic cells. A stop
codon was identiﬁed in exon 3 of the Chx10 gene (Fig. 3) truncat-
ing CHX10 in the homeodomain (Burmeister et al., 1996). No
CHX10 protein is detectable in orJ, therefore or J is a Chx10 null al-
lele. In human CHX10 null alleles, R20Q and R200P missense muta-
tions were located in the homeodomain (HOX) within the DNA
recognition helix (Ferda et al., 2000). The mouse Or J and human
CHX10 null phenotypes are virtually orthologous.
5. Cngb3 (cone cyclic nucleotide-gated (CNG) channel
b-subunit): cone degeneration (cd) dogsCNG cation channels are located in the photoreceptor plasma
membrane. CNG channels are heterotetrameric complexes
Fig. 4. The CNGB3 gene and protein. The cd phenotype of the German Shorthaired
pointer is caused by a missense mutation (D262 N) in exon 6 (TM domain 2). The
CNGB3 protein has six TM domains, a pore region (P), and a cNMP binding site. In
the Alaskan Malamute, the entire CNGB3 structural gene is deleted (the canine
CNGB3 is presently unavailable, therefore the defect is modeled on the mouse
CNGB3 gene).
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cones. Each subunit contains cGMP binding domains. Homo-
meric CNGA3 forms functional channels, while CNG3B does
not. The function of CNG channels is to regulate Ca2+/Na+ inﬂux
depending on the light- or dark-state of photoreceptors (corre-
sponding to low or high cytoplasmic cGMP, respectively).
Cone degeneration in the Alaskan Malamute was initially
termed hemeralopia (Rubin, Bourns, & Lord, 1967), and later chan-
ged to cone degeneration (cd) (Gropp et al., 1996). The cone disease
is recessive and resembles human achromatopsia caused by CNGB3
null alleles (total color blindness, ACHM3). The Alaskan Malamute
defect was identiﬁed as a deletion of the entire structural gene (all
18 exons) of the canine Cngb3 gene (Sidjanin et al., 2002). In an-
other breed affected by cd (German Shorthaired pointer), a mis-
sense mutation (D262 N) was detected in a conserved region of
CNGB3 encoded by exon 6 (Sidjanin et al., 2002), generating a null
allele (Fig. 4). Affected dogs develop day blindness at 8–12 weeks
of age when retina development is complete. Cone function is
detectable in very young cd puppies, perhaps due to the presence
of the channel-forming CNGA3 subunit. Cone ERG responses are
extinguished in adult cd dogs, although the affected retina remains
normal throughout life, as judged by ophthalmoscopy.
The cone CNG cation channel (stoichiometry B3 B3 A3 A3)
(Peng, Rich, & Varnum, 2004) is open in the dark when the photo-
transduction cascade is silent and cGMP is high. The channel closes
in light when cGMP is degraded by cGMP-speciﬁc phosphodiester-
ase (PDE6). In the absence of a functional CNGB3 subunit, a normal
channel cannot be assembled, cone phototransduction is disabled,
and the photoreceptor cannot hyperpolarize. Another consequence
of CNG3B deletion is downregulation of cone Tc (Gngt2) and cone
Tb (Gnb3) which were undetectable in predegenerate cd AM retina
(Akhmedov et al., 1998), presumably as a consequence of trafﬁck-
ing problems.
6. Crb1 (crumbs homolog 1): rd8 mouseFig. 5. The Crb1 gene and protein. An exon 9 frameshift leads to a truncation
removing the TM domain (gray). The extracellular domain of CRB1 has laminin G
(globular) motifs, multiple EGF-like domains (not shown), and two cysteine-rich
regions at the C- and N-termini (yellow). ‘D’ depicts the C-terminal deletion. Motifs
were determined with Motif Scan at http://hits.isb-sib.ch/cgi-bin/PFSCAN.CRB1 is a highly conserved transmembrane protein homologous
to Drosophila crumbs, a protein important for maintaining api-
co-basal cell polarity. CRB1 is expressed mostly in brain and ret-
ina. Nonsense or frameshift mutations in the human CRB1 gene
lead to various forms of human retinal dystrophy, including ret-
initis pigmentosa and LCA (den Hollander et al., 1999).
The rd8 mouse was isolated at The Jackson Laboratory by re-
peated backcrossing of rd6 mice with C57BL/6 mice on the basis
of a ‘large retinal spots’ phenotype (Mehalow et al., 2003). The
rd8 retina phenotype occurs due to a single base pair deletion in
exon 9 of the mouse Crb1 gene (nt3481). CRB1 is a 1406-residue
protein containing a 37-amino acid cytoplasmic domain with
PDZ motifs involved in organizing a macromolecular protein scaf-
fold (Gosens, den Hollander, Cremers, & Roepman, 2008). The func-tion of the large extracellular domain containing multiple EGF-like
and laminin-AG-like repeats is unknown. The rd8 mutation causes
a frameshift that truncates the protein. The truncated protein re-
tains the EGF-like and Laminin-like repeats, but lacks the trans-
membrane and cytoplasmic domains of CRB1 protein encoded by
exon 12 (Fig. 5).
Homozygous rd8mice show a slowly progressing retinal degen-
eration with relatively stable ERGs. Histology at 5 weeks of age
shows areas of retinal folding that correspond to the white retinal
spots (Chang et al., 2002). Contrasting with other retinal degener-
ation mutants, the rd8 degeneration is focal, i.e., sharply demar-
cated. A Crb1/ mouse also showed a relatively mild retinal
degeneration phenotype consisting of lesions disrupting interac-
tion between photoreceptors and Mueller cells (van de Pavert
et al., 2004).
7. Gnat2 (cone transducin a subunit): cpﬂ3 mouseCone transducin (cT, or Gct ) is the heterotrimeric G protein of the
cone phototransduction cascade, composed of cTa (Gnat2), cTb
(Gnb2), and cTc (Gngt2) subunits. Its role is analogous to that
of rod transducin in the rod phototransduction cascade. The pri-
mary function of cTa is to exchange GDPwith GTP upon receptor
activation, and to activate PDE to accelerate cGMP hydrolysis.
The structure of cTa is predicted to be very similar to rod Ta
(Noel, Hamm, & Sigler, 1993) showing two main domains, the
helical domain and the GTPase domain, ﬂanking the GDP/GTP
binding cleft. In human patients, GNAT2 null alleles cause auto-
somal recessive achromatopsia (color blindness, rod monochro-
macy) (Kohl et al., 2002; Rosenberg et al., 2004).
The cpﬂ3 mouse was identiﬁed by ERG testing as a novel achro-
matopsia model (Chang, Dacey, et al., 2006). Cpﬂ3/cpﬂ3 mice re-
vealed near normal scotopic ERGs, but cone ERGs were 25% of
normal b-wave amplitudes at 4 weeks, and were undetectable at
9 months of age. The defect appears as a missense mutation
(D200 N) in exon 6 of the Gnat2 gene, encoding cone transducin a
subunit (Fig. 6). D200 is in a highly conserved area of transducin
and may affect the GTPase activity of cone transducin (Kerov et al.,
2005). Using an AAV5 vector expressing mouse Gnat2 cDNA under
control of the human red–green opsin promoter, the cpﬂ3 pheno-
type could be rescued: postnatal injection into the subretinal space
of adult Gnat2cpﬂ3mouse eyes demonstrated that light-adapted ERG
amplitudes were at levels comparable to the wild-type controls.
Most treated eyes continued to have recordable light-adapted ERG
signals at 6 and 7 months of age (Alexander et al., 2007).
8. Gnb1 (transducin b-subunit): rd4 mouseTransducin (T, or Gt) is the heterotrimeric G protein of the rod
phototransduction cascade, composed of Ta (Gnat1), Tb (Gnb1)
Fig. 6. The murine Gnat2 gene and protein. The location of the Cpﬂ3 mutation is
indicated. Underneath, cartoon of the cTa protein. The numbers refer to amino acids
predicted to be in contact with GTPcS in the nucleotide binding cleft (Noel et al.,
1993). The mutant residue in cone Ta, D200 N, is situated within the GTP binding
cleft. Blue box, helical domain (HD). Yellow, b-sheets forming the GTPase domain.
Fig. 7. The Rd4 gene defect. The Rd4mouse chromosome 4 carries a large inversion
encompassing most of the chromosome. The proximal breakpoint is in the
centromere, the distal breakpoint is in intron 2 of the Gnb1 gene.
Fig. 8. The chicken GNB3 gene and the retinopathy globe enlarged (rge) gene defect.
The defect was determined to be a deletion of 3 bp in exon 6, deleting a single
amino acid (D163).
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tional change in rhodopsin after light absorption. Activated Ta
with GTP bound, in turn, activates cGMP phosphodiesterase
(PDE6) which degrades cGMP, the second-messenger in photo-
receptors. The Tb and Tc subunits form a tight complex that is
membrane-associated using a farnesyl anchor attached to the
C-terminus of Tc. The TbTc crystal structure shows that Tb
mainly consists of a seven-bladed propeller formed by seven
WD repeats (ﬂanked by conserved W and D residues).
The Rd4+/ mouse was found in stock carrying the inversion
In(4)56Rk, which was induced in a DBA/2 J male (Roderick, Chang,
Hawes, & Heckenlively, 1997). The inversion is very large and
encompasses nearly all of chromosome 4. The homozygous Rd4
mutation is lethal, but heterozygotes survive and exhibit autoso-
mal dominant retinal degeneration. The histological phenotype is
severe, the outer nuclear layer is reduced at 10 days of age, and ab-
sent at 6 weeks. Kitamura et al. (2006) demonstrated that the dis-
tal breakpoint of the inverted Rd4 chromosome 4 is localized in the
second intron of the Gnb1 gene encoding Tb, whereas the proximal
breakpoint lies within the centromere (Fig. 7). The second intron is
upstream of ATG in exon 3, and therefore no protein is produced in
the mutant since the promoter region is lost due to the inversion.
Tb in complex with Tc regulates the activity of transducin. In con-
trast to Ta (Gnat1), which is expressed only in rods, Tb is expressed
in brain, liver and other tissues, explaining the lethal effect of the
homozygous Rd4 mutation. In contrast to the severe effect of the
Gnb1 null allele, Gnat1 null mice exhibit a very slowly progressing
retinal degeneration (Calvert et al., 2000). In human, no CNB1
mutations associated with disease have been identiﬁed to date.
9. Gnb3 (cone tranducin b-subunit): retinopathy globe enlarged
(rge) chickenCone transducin is encoded by Gnat2 (a-subunit), Gnb3 (b-sub-
unit), and Gngt2 (c-subunit). The b-subunit is ubiquitously
expressed, but at particularly high levels in cones. A human
GNB3 splice variant is associated with hypertension, obesity
and diabetes. The structure of chicken GNB3 is likely very close
to bovine GNB1 which has been determined by crystallography(Sondek, Bohm, Lambright, Hamm, & Sigler, 1996). It consists
primarily of a seven-bladed b-propeller which contains seven
structurally similar WD repeats. WD repeats are commonly
found in other proteins, and consist of 40 amino acids ending
in conserved Trp (W) and Asp (D) residues.
Rge is a naturally occurring autosomal recessive retinal disorder
leading to blindness. The Rge chicken arose spontaneously in a Brit-
ish chicken ﬂock (Tummala et al., 2006). The ERG responses are re-
duced at hatch, but still measurable at one year. Notably, the
scotopic and photopic b-waves lack oscillatory potentials (Mon-
tiani-Ferreira, Shaw, Geller, & Petersen-Jones, 2007). The rge retina
shows early OPL disorganization and endoplasmic reticulum
mislocalization (Tummala et al., 2006). Older birds develop globe
enlargement and cataracts.
The rge defect was identiﬁed as a 3 bp deletion in exon 6 (Fig. 8)
eliminating one amino acid (D153), one of two highly conserved
aspartic acids in the third of the seven WD repeats. Normal and
mutant transcript levels are similar, but the mutant GNB3 protein
is 70% reduced. Modelling of the mutant GNB3 protein predicts
that b-sheets in propellers 1 and 5 are abolished by the deletion
of D153, thereby weakening the structure (Tummala et al., 2006).
10. Grm6 (metabotropic glutamate receptor 6 (mGluR6): nob3,
nob4 miceThe metabotropic glutamate receptors are a family of G protein-
coupled receptors responsive to L-glutamate. mGluR6 is a mem-
ber of group III family of metabotropic glutamate receptors
expressed in ON-bipolar cells. It couples to a downstream G
protein termed Gao, but the molecular identities of the target
enzyme and the synaptic cation channel are unknown.
The nob3 mouse mutant was discovered at The Jackson Labora-
tory on the basis of its ERG phenotype (Maddox et al., 2008). The
nob4 mutant was generated by ENU chemical mutagenesis and
screening of several generations of mutant mice (Pinto et al.,
2007). Both mutants have similar ERG and visual abnormalities
mimicking autosomal recessive congenital stationary night blind-
ness (CSNB). The nob3 and nob4 retinal morphologies are normal.
The most outstanding phenotype is lack of scotopic and photopic
b-waves; a-waves differ only slightly from those of WT.
Nob3 and nob4 have defects in the Grm6 gene encoding metab-
otropic glutamate receptor 6 (mgluR6) located in bipolar cell den-
dritic terminals. Gmr6(nob3) carries a C? T transition at position
648 of intron 1, a change that creates a new donor splice site and
a new short exon (exon 1a in Fig. 9B). The new exon derails the
ORF of the downstream exon truncating the mGluR6(nob3) pro-
tein. Nob4 carries a missense mutation (S185P) in exon 2
(Fig. 9A). S185 is located in the glutamate binding domain of
mgluR6, most likely affecting the trafﬁcking of mGluR6(S185P) to
ON-bipolar cell terminals and stability of the protein. Both mutants
are undetectable by immunoblot, therefore both mutations gener-
ate null alleles. Aside from absent b-waves, the null mutations
mostly affect the ON-bipolar cell pathway leading to a reduction
in visual function (nice review: McCall & Gregg, 2008). The nob4
phenotype is identical to that of the laboratory generated Grm6
knockout (Masu et al., 1995). Different sets of mutations in GRM6
Fig. 9. The Grm6 gene and nob3/nob4 gene defects. The Nob3mutant is generated by a SNP in intron 1 (C648T) that produces a new splice site. As a result, a new exon (X1a) is
created, as shown in B (red sequence). Grm6(nob4) contains a missense mutation in exon 2 (S185P). The blue boxes 1–7 indicate the seven TM domains of mGluR6.
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but human and mouse phenotypes are very similar.
11. Gucy2D (guanylate cyclase 1): rd (GUCY1B) chickenMembrane guanylate cyclases (GCs) synthesize cGMP, the sec-
ondary messenger of phototransduction. Photoreceptors con-
tain two GCs, here termed GC1 and GC2. GC1 and GC2 are
activated by two GC-activating proteins, termed GCAP1 and
GCAP2. GCAPs are Ca2+ sensors sensitive to changes in free
[Ca2+] in the cytoplasm of photoreceptors, and activate GCs in
low free [Ca2+]. This mechanism leads to restoration of dark
cGMP levels and opening of CNG channels in the ﬁnal step of
recovery from photobleaching.
The rd (GUCY1B) chicken is a naturally occurring blind mutant
discovered in a Rhode Island Red ﬂock about 30 years ago (re-
viewed in Semple-Rowland and Cheng (1999), Ulshafer, Allen,
Dawson, and Wolf (1984). As a hallmark, photoreceptors of the
rd/rd retina appeared normal at hatch, but without a measurable
electroretinogram. Degeneration of the rods and cones begins
approximately at P7, and progresses relatively slowly over many
months. The genetic defect (Fig. 10) is a large deletion of parts
the extracellular domain, the transmembrane domain and parts
of the kinase-like domain of GC1 (GUCY1B in chicken), generating
a null allele (Semple-Rowland & Lee, 2000; Semple-Rowland, Lee,
Van Hooser, Palczewski, & Baehr, 1998). In the absence of GC,
cGMP levels in the mutant retina were very low and unable to sus-
tain phototransduction, which presumably leads to permanent clo-
sure of the CNG channels and elimination of the dark current
(constitutive hyperpolarization). Vector-mediated expression of
bovine GC-E in the photoreceptors of rd chickens restored photore-
ceptor function in mutant animals demonstrating that the rd phe-
notype is indeed caused by deletion of GC-E (Williams et al., 2006).
The rd chicken phenotype closely mimics human LCA type 1
caused by a GUCY2D null allele (Perrault et al., 2000), but is distinctFig. 10. The gene defect of the retinal degeneration (rd) chicken, gene symbol
GUCY1B). Exons 4–7 were deleted and replaced by a 81 bp fragments with high
sequence similarity to exon 9. The deletion removes the single transmembrane
domain of guanylate cyclase 1 (Gucy2e in mouse). The defect is modeled on the
mouse Gucy2e gene (the chicken GC1 gene has not been cloned and sequenced).from that of the Gucy2e knockout mouse in which rod photorecep-
tors still function (Yang et al., 1999). This distinction is explained
by the ability of a closely related GC (Gucy2f) in mouse rods to
compensate for the loss of Gucy2e (Baehr et al., 2007). GUCY2F
apparently has lost this ability in chicken and human rods.
12. Mertk (receptor tyrosine kinase expressed in monocytes,
epithelia, and reproductive tissues): RCS (Royal College of
Surgeons) ratMERTK is expressed in monocytes and tissues of epithelial and
reproductive origin. Murine Mertk is homologue of the human
c-mer receptor tyrosine kinase proto-oncogene (Graham et al.,
1995).Mertk encodes a transmembrane protein with two extra-
cellular ﬁbronectin and two immunoglobulin-like domains, and
an intracellular tyrosine kinase domain. The MERTK polypep-
tide presumably plays a role in adhesion of the RPE to photore-
ceptor outer segments. Null mutations in the human MERTK
gene are associated with recessive RP (Gal et al., 2000) and
cone–rod dystrophy (McHenry et al., 2004).
The long-studied RCS rat is an animal model for recessive RP
(Bourne, Campbell, & Tansley, 1938). This rat strain was developed
by Richard Sidman and John Dowling from stock obtained from Ar-
nold Sorsby of the Royal College of Surgeons, London (hence the
name) (Dowling & Sidman, 1962; Reading & Sorsby, 1966). Con-
genic RCS strains were later established (LaVail, Sidman, & Ger-
hardt, 1975). The genetic defect renders the RPE unable to
phagocytose rod outer segments, a circadian-controlled disk shed-
ding process that is vital for rod and cone photoreceptor outer seg-
ment renewal. The RPE can bind, but is unable to ingest, shed outer
segment membrane. The rdy (retinal dystrophy) locus was identi-
ﬁed by positional cloning and gene sequencing revealed a deletion
of the second coding exon in the receptor tyrosine kinase mertk
(Fig. 11) (D’Cruz et al., 2000). Exon 3 is out of frame leading to
frameshift and a stop codon after codon 19. The consequences of
Mertk null allele include subretinal accumulation cellular debris,
and rod degeneration followed by cone degeneration as is typical
for recessive RP.
Numerous RPE transplantation experiments have been con-
ducted in the RCS rat since the early 1980s. Anatomical rescue
(thickness of outer nuclear layers) has been very encouraging,
although functional rescue (full-ﬁeld ERGs) has been very mixed
(review: Da Cruz, Chen, Ahmado, Greenwood, & Coffey, 2007).
AAV-MERTK delivery to an RCS rat retina resulted in correction of
the phagocytosis defect, increased sensitivity of treated eyes to
low intensity light, and photoreceptor preservation (Vollrath
et al., 2001).
Fig. 11. The Mertk gene and protein. In the RCS rat, exon 2 is deleted causing a frameshift, deleting all of the molecule after codon 19. MERTK has a protein kinase domain
(yellow), immunoglobulin-like domains (IG), and ﬁbronectin (FN) domains.
W. Baehr, J.M. Frederick / Vision Research 49 (2009) 2636–2652 264313. Mfrp (membrane-type frizzled–related protein): rd6 mouseMfrp is a recently identiﬁed gene encoding a frizzled-related
protein with a cysteine-rich domain, and a binding domain for
the WNT glycoproteins, which have important roles in embryo-
genesis. Mfrp is expressed in brain and RPE, its precise function
is unknown.
The rd6mousewas discovered in an inbredmouse strain, derived
from offspring of irradiatedmice. A congenic line was established at
The Jackson Laboratory (Hawes et al., 2000). Ophthalmoscopic
examinationof rd6/rd6mice showeddiscrete subretinal spots across
the retina, appearing by 8–10 weeks postnatally. The spots were
caused by large subretinal cells ﬁlled with membraneous and lipo-
fuscin-like material, a phenotype that resembles the human condi-
tion retinitis punctata albescens. Rd6 outer segments appear
disorganized and shorten progressively. The rd6 ONL is about half
thickness at 2 months of age (Won et al., 2008).
Rd6mice carry a donor splice mutation in the Mfrp gene caused
by a 4 bp insertion in intron 3, resulting in skipping of exon 4 (aa
91–140) without frameshift (Kameya et al., 2002) (Fig. 12). The
mutant Mfrp gene is a null allele (exon 4 contains a portion of
the transmembrane domain (TM)). Interestingly, the Mfrp gene is
expressed as a dicistronic message with C1qtnf5 (complement –
C1q tumor necrosis factor-related protein 5), producing an mRNA
with two open reading frames. MFRP (584 amino acids) has a (pre-
dicted) N-terminal transmembrane domain and C-terminal cys-
teine-rich frizzled-like domain (CRD) possibly involved in WntFig. 12. The Mfrp gene (rd6). Exon 4 (red) is skipped in the rd6 mouse. The Mfrp is
ﬂanked by C1qtnf5, such that the 30-UTR of Mfrp also is the 50-UTR of C1qtnf5
consisting of two exons. A bicistronic mRNA is transcribed where C1qtnf5 mRNA is
part of the 30UTR of Mfrp. The MFRP protein has a transmembrane domain (TM), an
extracellular cysteine-rich frizzled domain (fz) and two CUB domain proﬁles
(named after initials of Cir, Cis, uEGF, and bone morphogenetic protein) (Stohr,
Berger, Frohlich, & Weber, 2002).
Fig. 13. The mouse Myo7a gene and protein. Missense mutations sh16 J (exon 7) and sh
generated by ENU mutagenesis. R and E in the protein schematic are arginine- and glu
domains participate in the linkage of cytoplasmic proteins to the membrane.signalling. C1QTNF5 has a leader sequence and is likely secreted
into the interphotoreceptor matrix (Won et al., 2008). Both MFRP
and C1QTNF5 are associated with human retina disease (nanoph-
thalmos, a rare disorder of eye development characterized by ex-
treme hyperopia (farsightedness) and late-onset retinal macular
degeneration) (Shu et al., 2006; Sundin et al., 2005).
14. Myo7a (myosin VIIa): Shaker-1 (sh1) mouseMyosin VIIa is a molecular motor composed of two heavy chains
(250 kDa) that move towards the plus-end of actin ﬁlaments (or
barbed end, the site where the ﬁlaments grow). Myosin VIIa is
involved in light-dependent transport of RPE melanosomes
from the cell body to the apical processes.
The shaker-1 mouse is a model for Usher syndrome 1B (USH1B),
the most common form of blindness and deafness in humans (Weil
et al., 1995). Premature stop codons in the human MYO7A gene
cause cytoskeletal abnormalities, including abnormal organization
of microtubules in the cilium of photoreceptor cells, nasal cilia
cells, sperm cells, as well as widespread degeneration of the organ
of Corti (Weil et al., 1995).
The original shaker-1 mutation (sh1) was found as a naturally
occurring mutant on the Balb/C background (Lord & Gates, 1929)
and maintained at The Jackson Laboratory. Sh1/sh1 mice show cir-
cling, head-tossing, deafness, and hyperactivity phenotypes,
mainly due to inner ear dysfunction. The sh1 gene was shown to
encode a mutant form of the myosin VIIa motor carrying a mis-
sense mutation in the myosin head (Gibson et al., 1995). The muta-
tion corresponds to R241P on the myosin 7a isoform 1 (Fig. 13)
near a putative actin binding site. A second mutation, sh16J
(R241P, Fig. 11), arose on the C57BL background (Gibson et al.,
1995). Defective melanosome distribution in the retinal pigment
epithelium (RPE) of shaker-1 mice can be observed (Liu, Ondek,
& Williams, 1998). Myosin VIIA is also thought to facilitate opsin
transport in photoreceptors, however the sh1 retina does not
degenerate (Liu, Udovichenko, Brown, Steel, & Williams, 1999).
Williams and collaborators showed in a Myo7a null mouse
(4626SB allele, generated by ENU chemical mutagenesis) that in-
gested ROS membranes fail to clear normally during phagocytosis
by the RPE (Gibbs, Kitamoto, & Williams, 2003). Absence of Myo7a,
however, does not block phagocytosis.1 (exon 13) are located in the myosin head region. A third mutation, Q720ter, was
tamic acid-rich regions. Myth4 are predicted microtubule-binding domains, Ferm
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rd7 mouseFig. 15. The mouse Nyx gene and protein. The 85 bp deletion in exon 3 truncates
the protein, eliminating a predicted GPI anchor at the C-terminal region.Nuclear receptors are transcription factors which act as ligand-
inducible transcription regulators controlling the activity of
speciﬁc gene networks during development and differentiation
(Wurtz et al., 1996). NR2E3 is preferentially expressed in rods,
where it acts in concert with other transcription factors to reg-
ulate photoreceptor-speciﬁc gene expression.
Rd7 mice display recessive retinal degeneration characterized
by whorls and rosettes in the ONL. Rosettes form early, around
P13, but disappear eventually, around 16 months (Akhmedov
et al., 2000). Rosette-formation requires the presence of cones,
since transgenic ablation of cones prevents the phenotype (Chen
& Nathans, 2007). Onset of retinal degeneration is relatively late,
rod and cone ERGs are still  50% of normal at 16 months of age.
Recently it was shown that expression of the phenotype depends
on genetic modiﬁers present in some strains (Haider et al., 2008).
The rd7 gene was identiﬁed as a photoreceptor-speciﬁc nuclear
receptor NR2E3 (Akhmedov et al., 2000), also known as PNR
(Kobayashi et al., 1999). On the RNA level, the genetic defect was
identiﬁed as a deletion of exons 4 and 5 (Fig. 14) (Akhmedov
et al., 2000); a gene analysis revealed that exons 4 and 5 are si-
lenced by multiple mutations, including a nonsense codon, and
skipped by alternative splicing (Haider, Naggert, & Nishina,
2001). Exons 4 and 5 encode a ligand-binding domain (LBD) typical
of nuclear hormone receptors (Wurtz et al., 1996), but no ligand
has been identiﬁed. Exons 1–3 encode the DNA binding domain
containing two Zinc-ﬁnger motifs. Nearly simultaneously with
identiﬁcation of the rd7 gene, mutations in the human NR2E3 gene
were shown to cause recessive ‘‘enhanced S-cone syndrome”
(ESCS), characterized by 30x elevated S-cone sensitivity (Haider
et al., 2000) and increased number of cones (Milam et al., 2002).
Correspondingly, the rd7/rd7 retina shows a signiﬁcant increase
in cones expressing S-opsin (2–3-fold) (Haider et al., 2001). The
expression pattern of NR2E suggests that it may serve as a repres-
sor for cone cell proliferation (Haider et al., 2001), likely in concert
with other transcription factors (Cheng et al., 2004).
16. Nyx (Nyctalopin): nob mouseNyctalopin (nyctalopia = nightblindness) is a small leucine-rich
glycoprotein of unknown function, belonging to a larger family
of leucine-rich proteoglycans. Its closest relatives by sequence
are chondroadherins (31% identity), glycoprotein 5 (31%) and
synleurin (28%).
The nob (no rod b-wave) mouse was identiﬁed by ERG in 1990
and is now recognized as a model for complete X-linked congenital
stationary nightblindness (CSNB1A). The rod a-wave and the cone
ERG responses are normal, suggesting functioning photoreceptors
with no morphological abnormalities (Pardue, McCall, LaVail,
Gregg, & Peachey, 1998). The nob ERG phenotype is similar to that
observed with Grm6/ (mGluR6) and Gnao1/ (Go alpha subunit)
knockout mice (Dhingra et al., 2000; Masu et al., 1995).Fig. 14. The Nr2e3 gene and protein. Multiple mutations, including a nonsense
mutation, silence exons 4 and 5 that encode part of a ligand-binding domain.The nob gene, located on the X chromosome, was shown to en-
code a novel protein termed nyctalopin, a small leucine-rich glyco-
protein (SLRPs) (Gregg et al., 2003). It has an N-terminal leader
sequence and is predicted to be GPI-anchored, but biochemistry
showing this is absent. The nyx sequence shows several LRRs (leu-
cine-rich repeats) which are 20–29 residue sequence motifs pres-
ent in many proteins that participate in protein–protein
interactions. The mouse nyx gene contains three exons, most of
the protein is encoded by exon 3. The nob gene defect consists of
an 85-bp deletion in exon 3 (Fig. 15). This deletion causes a frame-
shift that adds 170 foreign C-terminal amino acids to the 188-res-
idue N-terminal portion of nyctalopin, likely eliminating protein
function.
The nyx gene is expressed in the ONL, INL, and GCL (Gregg et al.,
2003), and nyctalopin can be immunolocalized to the OPL (photo-
receptor/bipolar cell synapse) and the INL (rod bipolar cells) (Mor-
gans, Ren, & Akileswaran, 2006). Transgenic expression of
nyctalopin-EYFP under the control of the murine GABACq1 pro-
moter rescued the nob phenotype. The fusion protein was detected
exclusively in the OPL, at the depolarizing bipolar cell dendritic ter-
minals, and colocalizing with metabotropic glutamate receptor 6
(Gregg et al., 2007).17. PDE6a (PDE6a-subunit): rcd3 Cardigan Welsh corgi dogCyclic GMP phosphodiesterase 6 (PDE6), the target enzyme in
the phototransduction cascade, is comprised of two catalytic
subunits (PDE6a and PDE6b) and two identical inhibitory sub-
units (PDE6c). PDE6ab activity is controlled by the transducin
a-subunit charged with GTP which displaces PDEc from its
inhibitory site during the activation phase. Activation produces
hydrolysis of cytoplasmic cGMP, closure of CNG-gated cation
channels and hyperpolarization of the photoreceptor. Muta-
tions in the human PDE6A gene causing recessive RP in humans
are relatively common (Dryja, Rucinski, Chen, & Berson, 1999;
Huang et al., 1995).
Progressive retinal atrophy (PRA) in the Cardigan Welsh corgi
was recorded ﬁrst in the 1970s (Keep, 1972). Mutant puppies fail
to develop normal rod ERGs and exhibited reduced cone a-wave
amplitudes (Tuntivanich et al., 2009). Elaboration of outer segment
membrane stagnates and photoreceptors eventually degenerate.
The rcd3 defect consists of a 1-bp deletion in exon 15 of the PDE6A
gene encoding the PDEa subunit (Fig. 16) (Petersen-Jones, Entz, &
Sargan, 1999). The deletion produces a frameshift at codon 616
that truncates the PDEa subunit. Twenty-eight foreign residues
are added at the C-terminus by the frameshift. If produced, the
truncated protein would lack part of the catalytic domain and
the farnesylated C-terminus. The hydrophobic farnesyl chain acts
as membrane anchor tethering PDE6a to the disk membrane. The
result of the truncation is an inactive PDE, most likely increasing
cytoplasmic cGMP to toxic levels and leading to apoptosis.
The PRA phenotype in this animal is similar to that of the rcd1
Irish setter carrying a null mutation in the PDE6b gene, described
as arrest in photoreceptor development and early onset photore-
ceptor cell degeneration (Suber et al., 1993). Mouse models with
Fig. 16. The canine PDE6a gene. The rcd3 PDE6a gene defect is a deletion of 1 nt in
exon 15 (CAT domain, red). Also shown are two missense mutations (V685 M,
D670G) generated by ENU mutagenesis in exons 18 and 19 of the mouse (canine
and mouse PDE6a gene structures are identical). GAF1 and GAF2 contain noncat-
alytic cGMP binding sites. Fa denotes farnesylation of the C-terminal cysteine.
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ENU chemical mutagenesis (Sakamoto, McCluskey, Wensel, Nagg-
ert, & Nishina, 2009).18. PDE6b (PDE6 b-subunit): rd1/rodless mouse; rd10 mousePDE6b and PDE6a are the catalytic subunits of rod PDE6.
Domain structures of the two subunits are identical. The N-ter-
minal half of each protein carries two non-catalytic cGMP bind-
ing sites, termed GAF domains (Martinez, Beavo, & Hol, 2002),
whereas the C-terminal half harbours the catalytic domain. C-
terminal cysteines are isoprenylated, a modiﬁcation required
for membrane association and vesicular transport. A functional
PDE is critical for normal phototransduction. In human, PDE6B
null alleles are associated with recessive RP (McLaughlin, Ehr-
hart, Berson, & Dryja, 1995), and a H258 N missense mutation
with dominant congenital stationary nightblindness (CSNBAD2)
(Gal, Orth, Baehr, Schwinger, & Rosenberg, 1994).
Rodless, rd1 mouse. Over 80 years ago, Clyde Keeler ﬁrst de-
scribed a naturally occurring mouse model of retinal degeneration
(Fig. 17) (Keeler, 1924). Some of his mice lacked rod photorecep-
tors (rodless, gene symbol r), a phenotype that segregated as an
autosomal recessive trait. Keeler viewed this phenotype as a failure
of development because PN6 retinas were normal histologically.
Keeler’s entire r colony, and all other known r stocks, were lost
by the end of World War II (Keeler, 1966).
Wild mice caught near Basel, Switzerland. were shown to have
retinal degeneration by ophthalmoscopy (Brueckner, 1951). Prog-Fig. 17. Transverse section of rodless mouse retina. Left, a histological section
generated by Clyde E. Keeler, re-photographed in 1993. The section, gifted to
Richard Sidman in the 1960s, was used for DNA extraction and PCR ampliﬁcation
(Pittler et al., 1993). Right, camera lucida drawing of rodless retina published by
Keeler (1924).eny of Brueckner’s mice were analyzed by several research groups
(reviewed by Farber, Flannery, and Bowes-Rickman (1994), Pittler,
Keeler, Sidman, and Baehr (1993)), who determined that the
degeneration of partially differentiated photoreceptor cells was
probably unrelated to Keeler’s rodless retina, and therefore war-
ranted a formal gene designation, retinal degeneration (gene sym-
bol, rd). Reduced photoreceptor PDE activity with a resultant
increase in cGMP levels (Farber & Lolley, 1974), mapping of the
rd gene to mouse chromosome 5 (Sidman & Green, 1965), and link-
age of Pde6b to rd (Danciger, Bowes, Kozak, LaVail, & Farber, 1990)
focused attention on PDE6B as the causative gene. The Pde6b iden-
tity of the rd gene was established by subtractive cloning (Bowes
et al., 1990) and by the identiﬁcation of a nonsense mutation in
exon 7 (codon 347) of the Pde6b gene (Pittler & Baehr, 1991)
(Fig. 18). Determination as to whether r and rd were different
genes was achieved when Steve Pittler extracted DNA from a
microscope slide (Fig. 17) of Keeler’s vintage-1924 r/r retinal tissue.
Ampliﬁcation and sequencing of r exon 7 unambiguously estab-
lished that r and rd were allelic, carrying the same nonsense muta-
tion (Y347ter) (Pittler et al., 1993). Consequently, we assume that r
mice survived WWII unknowingly and were re-discovered as rd
mice (now classiﬁed as rd1).
The rd1/rodless phenotype consists of arrested photoreceptor
development at P8–10, failure to elaborate normal outer segment
structure, and rapid degeneration following eye opening at P12.
By P17, 98% of rod nuclei have degenerated but cones are still pres-
ent (Carter-Dawson, LaVail, & Sidman, 1978). At 18 months, only
about 1.5% of cones remain (Carter-Dawson et al, 1979). Transient
rescue of the degeneration phenotype by a bovine Pde6b gene con-
struct under control of the opsin promoter demonstrated that the
Pde6b defect produces the rd1 phenotype (Lem et al., 1992). Gene
therapy with rAAV expressing mouse PDEb (Bennett et al., 1996)
and HIV expressing HA-tagged PDEb (Takahashi, Miyoshi, Verma,
& Gage, 1999) were encouraging, although less successful. Single-
stranded oligonucleotides were directed for an innovative, targeted
gene repair in the rd1mouse, but repair was estimated at less than
1% (Andrieu-Soler et al., 2007).
The rd10 mutant mouse, ﬁrst reported in 2002 (Chang et al.,
2002), carries a missense mutation (R560C) in exon 13 of the Pde6b
gene (Fig. 18) (Chang et al., 2007). A secondmissense mutation was
identiﬁed in exon 16 (L659P) of the nmf137 strain which arose after
ENU chemical mutagenesis. Both strains show autosomal recessive
inheritance patterns. The nmf137 strain showed retinal degenera-
tion at P21 but has not been further characterized. Both mutations
are in the catalytic domain of PDEb probably diminishing PDE
activity. Retinal degeneration in rd10/rd10 mice begins later than
in the rd1 mouse (measurable scotopic ERG at P18–P30) but even-
tually progresses similarly as in the rd1 mouse: rods have disap-
peared by P30–35, cones die later. PDE b immunoreactivity was
detectable at reduced levels at P10 (it is undetectable in rd1 retina).
Interestingly, dark-rearing rd10 mice delayed degeneration for at
least a week. A recent study with rd10 mice showed that photore-
ceptor cell death is accompanied by dendritic retraction of bipolar
and horizontal cells (Gargini, Terzibasi, Mazzoni, & Strettoi, 2007),
consistent with retinal remodelling observed in degeneration mod-
els (Jones et al., 2003). Gene therapy using an AAV serotype 5 vec-
tor expressing PDE6b under the control of the chicken b-actin
promoter showed signiﬁcant delay of retinal degeneration of the
rd10 phenotype (Pang et al., 2008).19. PDE6b (PDE6 b-subunit): rcd1 Irish setter and Sloughi dog
The rcd1 Irish setter, a prominent show dog, was the second ani-
mal species in which a retinal degeneration was recognized early
(1930s) (Parry, 1953). The recessive rod/cone dysplasia leads to a
Fig. 18. The mouse Pde6b gene and protein. The rd1 Pde6b gene carries a proviral insertion in intron 1 and a disease-causing stop codon in exon 7. Exon 21 mutations found in
rcd1 Irish setter and Sloughi dog are shown in blue. Relevant PDE6B domains: GAF domains (black), catalytic domain (red) and prenylated C-terminus (yellow). GAF domains
are cyclic GMP binding sites, named after proteins that contain them: cGMP-speciﬁc and -regulated cNMP PDEs, Adenylyl cyclase, and E. coli transcription factor FhlA.
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1982). First signs include arrest in photoreceptor development (no
outer segment formation), rod degeneration and later, cone degen-
eration followed by inner retina remodelling – a phenotype typical
for human recessive RP. Nearly all rods have degenerated by
5 months, and cone degeneration follows by about 1 year. cGMP
levels increase 10-fold over those of age-matched controls, which
is reminiscent of the rd1 mouse phenotype. The rcd1 defect was
determined to be a nonsense amber mutation at codon 807
(W807ter) (Clements, Gregory, Peterson-Jones, Sargan, & Bhattach-
arya, 1993; Suber et al., 1993) leading to a truncation of the PDEb
subunit (Fig. 18). The truncation removes 49 amino acids of the C-
terminal region, including the geranylgeranylated C-terminus that
mediates PDE membrane association. Although the PDEa subunit
is unaffected and detectable by immunoblot, no PDE activity is
measurable (Suber et al., 1993). This mutation is unidentiﬁed in
other dog breeds.
Sloughi dog. Blindness in Sloughi dogs was ascribed to an 8-bp
insertion after codon 816 truncating the protein similarly as ob-
served in the rcd1 Irish setter (Fig. 18) (Dekomien, Runte, Godde,
& Epplen, 2000). This mutation cosegregates with disease status
in a large pedigree.
20. Prph2 (peripherin/rds): rd2 mousePeripherin/rds is a tetraspanning integral membrane protein
required for structural stability of outer segmentmembrane. Per-
ipherin/rds is related in sequence and origin to Rom1, another
tetraspanning integral membrane protein with which it forms
heterotetrameric complexes (Goldberg & Molday, 1996).
The retinal degeneration slow (rds) mouse is a naturally occur-
ring Prph2 knockout (Van Nie, Ivanyi, & Demant, 1978). This mu-
tant was named ‘‘retinal degeneration slow” because its rate of
degeneration was much slower relative to that of the rd mouse.
Rd2 mice are unable to form outer segments (Sanyal & Jansen,
1981), and reveal no scotopic or photopic ERG response (for re-
view, see Goldberg (2006)). Although the degeneration begins at
PN14, it takes nearly a full year for the ONL to disappear com-Fig. 19. The Prph2 gene and rds mutation. The gene product is a glycoprotein with
four TM domains. A large insert of foreign DNA into exon 2 produces the Prph2 null
allele. The red bar designates a sorting signal required for transport to the OS (Tam,
Moritz, & Papermaster, 2004).pletely. Heterozygous mice have disorganized outer segments
likely due to haploinsufﬁciency. Prph2 cDNA was identiﬁed by sub-
tractive cDNA cloning and the gene product was shown to be a tet-
raspanning glycoprotein localized to the periphery of disc
membranes (Travis, Brennan, Danielson, Kozak, & Sutcliffe, 1989).
The genetic defect was shown to consist of a 9.2 kb insertion of for-
eign DNA into exon 2 (after N229) of the Prph2 gene (Ma et al.,
1995; Travis et al., 1989), an insert that is contained in the rd2
mRNA (Fig. 19). The insertion causes a frameshift and truncation
removing 117 C-terminal residues including the 4th TM domain
and a sorting signal required for transport to the outer segment.
The entire insertion is contained in the mutant rd2 mRNA. Final
evidence that the cloned gene represented Prph2 was provided
by transgenic rescue of the rd2 phenotype using a mouse opsin
promoter/Prph2 cDNA construct (Travis, Groshan, Lloyd, & Bok,
1992). Several efforts have been directed towards gene replace-
ment therapy since mutations in the PRPH2 gene are associated
with dominant retinitis pigmentosa, dominant macular dystrophy,
digenic retinitis pigmentosa with ROM1, and dominant adult vitelli-
form macular dystrophy. Subretinal injection of recombinant AAV
expressing Peripherin/rds resulted in stable generation of outer
segment discs (Ali et al., 2000; Sarra et al., 2001).
21. Rd3: rd3 mouse
Mice designated as rd3 were originally collected in Switzerland
in 1969, and shown to have retinal degeneration at The Jackson
Laboratory (Chang et al., 2002). Photoreceptors start to degenerate
at P14–21, and degeneration is complete at 16 weeks. The rd3 gene
(three exons, ﬁrst exon in 50-UTR) was identiﬁed by positional
cloning (Friedman et al., 2006) and shown to encode a 195-residue
(22 kDa) soluble protein of unknown function. The rd3 mutation
results in a stop codon in exon 3 after codon 106 (Fig. 20). A donor
splice site mutation at the end of exon 2 was observed in two sib-
lings with LCA (Friedman et al., 2006).
22. Rho (rhodopsin): English mastiff dogRhodopsin (Rho) is a G-protein coupled receptor (GPCR) present
in rod photoreceptors. It is a heptaspanning transmembraneFig. 20. The rd3 gene and proteins. The RD3 protein has no recognizable motifs. The
mutation truncates the protein by 89 residues.
Fig. 21. The Rpe65 gene. The Briard gene defect is a 4 nt deletion in exon 5. The rd12
mouse carries a stop codon in exon 3 (canine and murine Rpe65 genes structures
are identical).
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vated by light, an event that initiates the phototransduction
cascade which results in visual perceptions by the CNS. Numer-
ous mutations in the human RHO gene are known to cause auto-
somal dominant retinitis pigmentosa, a progressive retinal
degeneration affecting rods ﬁrst, then cones, and eventually
leading to blindness.
To identify English Mastiff dogs affected by PRA, roughly 500
dogs were screened and 29 affected were identiﬁed (Kijas, Miller,
Pearce-Kelling, Aguirre, & Acland, 2003). Genetic analysis revealed
a point mutation in exon 1 producing an amino acid change (T4R)
(Kijas et al., 2002). T4 is located at the intradiscal (extracellular)
side, and is predicted to affect the N-glycosylation of N2. Subse-
quent biochemical analysis showed that Rho(T4R) was unglycosy-
lated at N2, whereas glycosylation at N15 was unaffected (Zhu
et al., 2004). The mutant opsin localized normally to the rod outer
segments indicating that biosynthesis and vesicular transport was
unaffected in T4R/+ dogs. Light-activated Rho(T4R) lost its chromo-
phore faster and was less resistant to heat denaturation. Zhu et al.
proposed that the deleterious effect of the T4R mutation may be
mediated by T4R-opsin rather the Rho(T4R). Structurally, the
mutation was suggested to affect mainly the ‘‘plug” at the intradi-
scal side of Rho which may protect the chromophore of rhodopsin
from access by water (Zhu et al., 2004).
Affected dogs exhibit a slowly progressing retinal degeneration
that mimics dominant RP in humans with T4 K RHO mutations,
including a slowed time course of rod recovery after light exposure.
Mutant dogs are clinically normal for the ﬁrst several months of
life before disease onset, and therefore present an animal model
for adRP ideally suited for gene therapy. Cideciyan et al. showed
that clinical photography caused retinal degeneration in the exact
montage pattern on the retina as the circular light ﬂashes. Addi-
tionally, degeneration rate correlated with light-dosage: moderate
doses of light caused slow degeneration while higher doses of light
accelerated retinal degeneration (Cideciyan et al., 2005).
23. Rpe65 (RPE protein of 65 kDa): Swedish Briard/Briard
Beagle, rd12 mouseRPE65, a 65 kDa microsomal protein of the retinal pigment epi-
thelium (RPE), isomerizes all-trans-retinol to 11-cis-retinol
using retinyl esters as substrates (Jin, Li, Moghrabi, Sun, & Tra-
vis, 2005; Moiseyev et al., 2003). Without RPE65, the visual pig-
ment chromophore (11-cis-retinal) cannot be regenerated by
the retinoid cycle, visual pigments are largely nonfunctional,
and photoreceptor cells degenerate.
The Briard dog, originally described as being affected by con-
genital stationary night blindness (CSNB), manifests visual abnor-
malities of variable degree (Narfstrom, Wrigstad, & Nilsson,
1989). Affected dogs are congenitally night blind, have much re-
duced day vision, but have normal-appearing fundi. The gene de-
fect was identiﬁed as a 4-bp deletion (485delAAGA) in the mRNA
encoding RPE65 (Aguirre et al., 1998; Veske, Nilsson, Narfstrom,
& Gal, 1999). The deletion produces a frameshift and premature
termination of the polypeptide chain after codon 153 in exon 5
(Fig. 21). The mutant protein includes 52 RPE65-unrelated amino
acids from residue 153 onward.
Clinical features of the canine disease are quite similar to those
described in human. Multiple mutations in this gene are associated
with severe, early onset recessive LCA in humans (LCA-2 or RPE65-
LCA) (den Hollander et al., 2008; Thompson & Gal, 2003).
The rd12mouse is a naturally occurring Rpe65 null mutant that
was discovered in a single male mouse (Pang et al., 2005). Homo-
zygous rd12 mice develop white spots visible throughout the fun-
dus by ophthalmoscopy after 5 months of age. Scotopic ERGresponses are severely attenuated while photopic responses are
recordable. The gene defect was identiﬁed as a stop codon in exon
3, truncating RPE65 at codon 44 (R44ter) (Fig. 21). Phenotypically,
Rpe65/ and rd12 mice are very similar.
In recent years, much emphasis was directed towards gene
replacement therapy to develop treatments in Rpe65 null dogs
and mice, with encouraging and signiﬁcant success. Particularly
large animal models like the Briard Beagle were considered very
attractive to test the efﬁcacy of gene-based therapies in human pa-
tients. As proof of principle, one eye of a Briard dog, called ‘‘Lance-
lot”, blind since birth, was injected intraocularly with AAV2/2 virus
expressing RPE65. Lancelot and other Briards showed signiﬁcant
improvement of ERG responses that were stable for more than
3 years (Acland et al., 2001, 2005b). A breakthrough was recently
achieved in a phase 1 trial with human LCA2 patients using recom-
binant AAV-RPE65 virus (Maguire et al., 2008). While normal vi-
sion was not yet achieved, progress towards this goal has been
made.
24. Rpgrip (RPGR-interacting protein): Miniature Longhaired
DachshundRPGRIP interacts with RPGR through the C-terminal RID (RPGR-
interacting domain). RPGRIP and RPGR are localized to the pho-
toreceptor cilium in mouse, and RPGRIP is required for correct
localization of RPGR. Both proteins are involved in intraﬂagellar
transport through the cilium. Mutations in the RID domain of
human RPGRIP gene are associated with LCA.
The Miniature Longhaired Dachshund (MLDH) is the ﬁrst canine
cone–rod dystrophy model for which the mutation has been char-
acterized (Lheriteau et al., 2009). The MLDH is a model for reces-
sive cone–rod dystrophy, a rare disease typically characterized by
early loss of cone photoreceptors. In homozygous MLDH, the
30 Hz cone ﬂicker was barely detectable at 2 months (Turney
et al., 2007), and the cone ERGs was reduced at 6 months of age,
followed by rod b-wave reduction at a later stage (Lheriteau
et al., 2009). At 40 weeks, both rod and cone ERGs are unrecord-
able. A thinning of the ONL was followed by complete disappear-
ance of the inner retina at 10 years of age (Lheriteau et al., 2009).
The genetic defect was identiﬁed as a 44 bp insertion in exon 2,
close to the donor splice site. The insertion alters the reading frame
leading to a premature stop in exon 3 (Mellersh et al., 2006). The
insertion contains a stretch of 29 A ﬂanked by 15 bp perfect
repeats.
25. RPGR (Retinitis pigmentosa GTPase Regulator): XLPRA1,
XLPRA2 in dogsThe Rpgr gene, located on the X chromosome, generates multi-
ple splice variants of unknown function. The Rpgr-ORF15 vari-
ant is most important for photoreceptor function. Multiple
Fig. 22. The canine Rpgr gene has a complex splicing pattern. The transcript containing the RCC1 (sequence similarity to regulator of chromatin condensation) domain
encoded by exons 1–11, and the exon ORF14/15 is shown underneath the gene structure. Mutations causative for XLPRA1 and XLPRA2 are both located in ORF14/15 within a
100-bp interval. The ‘‘constitutive” transcript consisting of exons 1–13 and 16–19 is not depicted.
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linked RP (RP3). In mouse, RPGR is expressed in connecting cilia
of rods and cones suggesting a function related to ciliary struc-
ture or intraﬂagellar transport.
The phenotype of the canine disease, ‘‘X-linked progressive ret-
inal atrophy” (XLPRA), is similar to human RP3, an X-linked form of
retinitis pigmentosa, caused by mutations in the orthologous hu-
man gene. The original XLPRA was identiﬁed in Siberian Huskies,
a naturally occurring mutant. XLPRA has been renamed XLPRA1
to distinguish it from a second disease, XLPRA2, mapping to the
same gene (Zhang et al., 2002), but exhibiting a distinct phenotype.
XLPRA2 was identiﬁed in a mixed breed (mongrel) dog and could
not be traced to a speciﬁc breed (Zangerl, Johnson, Acland, & Agu-
irre, 2007). The XLPRA1 gene defect is a 5-bp deletion in the ORF15
exon of the Rpgr gene, resulting in a frameshift followed immedi-
ately by a stop and removal of 230 C-terminal residues (Fig. 22).
The XLPRA2 gene defect is a 2-bp deletion in ORF15, resulting in
a frameshift and the addition of 34 foreign amino acids. Both muta-
tions are located within a 100-bp interval in ORF15 (Zhang et al.,
2002). Functions of the constitutive variant of RPGR (consisting
of exons 1–19) and the ORF15 splice variant (lacking exons 16–
19) are unknown.
XLPRA1 photoreceptors show normal morphology until early
adulthood. After age 6 months, the photoreceptor layer develops se-
vere anomalies and retinal degeneration ensues. As is typical for RP,
cones appear to survive longer. In XLPRA2, disease phenotype is
more severe, retina development is aberrant, and outer segments
arehighlydisorganizedanddisorientedduringphotoreceptordevel-
opment (Beltran, Hammond, Acland, & Aguirre, 2006). Scotopic and
photopic ERG responses in XLPRA1 are stable for more than 1 year,
but decline signiﬁcantly by2.5 years (Zhang et al., 2002). In contrast,
XLPRA2 scotopic ERG responses are absent by 1 year of age.
26. Tub (tubby protein or TUB): tubby (rd5) mouseFig. 24. The tubby gene defect is a G > T conversion of the ﬁrst nucleotide of intron
11 (pos. 18,626 of the murine Tub gene, numbering starting with ATG), abolishing
the donor splice site and deleting exon 12. NLS, putative nuclear localization signals
(K39KKR, R301KRKKsK). PIP2, phosphatidylinositol(4,5)bisphosphate binding site.The function of the TUB protein, a member of the tubby-like
protein (TULP) family, is unknown. TUB is anchored to the cyto-
solic side of the plasma membrane by its afﬁnity to membrane-
associated phosphatidylinositol(4,5)bisphosphate (PIP2). CrystalFig. 23. The canine Rpgrip gene. A 44 bp insertion (shaded blue), a stretch of 29 A ﬂanked
exon 3 (shaded green). (Adapted from Mellersh et al., 2006).structures show that the side chain of K330 intercalates
between the two phosphate groups (Santagata et al., 2001). This
interaction is abolished by activation of Gaq and PLCb which
hydrolyses PIP2. The GPCR and the ligand of this cascade have
not been identiﬁed. Subsequently TUB translocates to the
nucleus where it may be involved in gene regulation (reviewed
in Carroll, Gomez, and Shapiro (2004)).
The tubby mouse arose spontaneously in a mouse colony at The
Jackson Laboratory (Chang et al., 2002; Coleman & Eicher, 1990).
The tubby phenotype is characterized by late onset obesity, reti-
nal/cochlear degeneration, reduced fertility, and insulin resistance.
The combination of these phenotypes resembles Usher Syndromes
(retinal and cochlear degenerations), Bardet-Biedl and Alstr}om syn-
dromes (obesity and neurosensory deﬁcits). In the tubby mouse,
retinal degeneration begins around P21. The ERG responses are
never normal, and are extinct at around 6 months of age. Obesity
is observed relatively late, beginning at about age 3 months Fig. 23.
The tub gene was identiﬁed by positional cloning (Kleyn et al.,
1996; Noben-Trauth, Naggert, North, & Nishina, 1996). TUB is ex-
pressed in hair cells of the organ of Corti, in retinal ganglion cells,
and inner segments of photoreceptors. The phenotype arose by
mutation of a donor splice site at the 30 end of exon 11, abolishing
splicing of intron 11 (Fig. 24). Retaining intron 11 resulted in trun-
cation of 44 native amino acids of the TUB C-terminus, and addi-
tion of 20 foreign amino acids. The tubby phenotype is identicalby two 15 bp perfect repeats, alters the reading frame leading to a premature stop in
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(Stubdal et al., 2000) conﬁrming that the tubby mutation is a null
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